Journal Article DKFZ-2020-01050

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2020
Springer Heidelberg

BMC cancer 20(1), 523 () [10.1186/s12885-020-07008-8]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Note: #EA:B310#LA:B310#

Contributing Institute(s):
  1. KKE Pädiatrische Onkologie (B310)
  2. DKTK HD zentral (HD01)
  3. B062 Pädiatrische Neuroonkologie (B062)
  4. Epigenomik (B370)
  5. Neuroimmunologie und Hirntumorimmunologie (D170)
  6. E010 Radiologie (E010)
  7. C060 Biostatistik (C060)
  8. Pediatric Glioma (B360)
Research Program(s):
  1. 312 - Functional and structural genomics (POF3-312) (POF3-312)

Appears in the scientific report 2020
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > D170
Institute Collections > E010
Public records
Publications database

 Record created 2020-06-12, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)